Multimodality imaging in carcinoid heart disease.
Ali M AghaJuan Lopez-MatteiTeodora DonisanDinu BalanescuCezar A IliescuJose BanchsPeter Y KimNicolas L PalaskasSyed YusufGreg GladishSaamir A HassanPublished in: Open heart (2019)
Neuroendocrine neoplasms arise from the gastrointestinal tract and can lead to carcinoid syndrome. Carcinoid heart disease affects more than half of these patients and is the initial presentation of carcinoid syndrome in up to 20 % of patients. Carcinoid heart disease typically leads to valve dysfunction, but in rare instances, carcinoid tumours can also metastasise to the endocardium and myocardium. Cardiovascular imaging plays an integral role in the diagnosis and prognosis of carcinoid heart disease. The use of multimodality imaging techniques including echocardiography, cardiac MRI, cardiovascular CT and positron emission tomography have allowed for a more comprehensive assessment of carcinoid heart disease. In this review, we discuss the features of carcinoid heart disease observed on multimodality imaging, indications for obtaining imaging studies and their role in carcinoid heart disease management.
Keyphrases
- pulmonary hypertension
- high resolution
- positron emission tomography
- end stage renal disease
- computed tomography
- ejection fraction
- chronic kidney disease
- newly diagnosed
- magnetic resonance imaging
- peritoneal dialysis
- case report
- oxidative stress
- prognostic factors
- contrast enhanced
- fluorescence imaging
- aortic stenosis
- patient reported outcomes
- mass spectrometry
- coronary artery disease
- transcatheter aortic valve replacement
- dual energy